Back to results
US 2014/0271665 A1Published application
Combinations of Kinase Inhibitors for the Treatment of Cancer
AssigneesExelixis, Inc., Sanofi, Vanderbilt University
InventorsDana T. Aftab, Carlos L. Arteaga, Veronique Blanc, Anindita Chakrabarty, Marielle Chiron-Blonde, Celine Nicolazzi, Ariella Hanker, Loic Vincent
Life of this patent
Estimating the term…
Abstract
The present invention provides methods of treating cancer by administering a compound of formula I, optionally as a pharmaceutically acceptable salt, solvate and/or hydrate thereof, in combination with an inhibitor that targets HER2 and/or HER3.
Claims17
1-16. (canceled)
A method for treating cancer in a patient comprising co-administering a therapeutically effective amount of Compound A and a therapeutically effective amount an anti-HER3 antibody.
20-26. (canceled)
(canceled)
Dependencies are inferred from the claim text.